Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides
By Solomon P. Wasser. Applied Microbiology and Biotechnology, 2002
2,217 citations recorded by the source corpus.
Subfields: Complementary and alternative medicine, Pharmacology, Plant Science
View Paper: https://www.semanticscholar.org/paper/dd4556cec4275326ebf88efeb0d1a3b7fc1ac9c0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Complementary and alternative medicine
In Pharmacology
In Plant Science
Citations in the corpus
- Nutritional Composition of Some Wild Edible Mushrooms (2009, neutral): “Some edible mushroom species are sources of physiological agents for medicinal applications, possessing antitumour, cardiovascular, antiviral, antibacterial and other activities (3,4,5).”
- Azaphilones: a class of fungal metabolites with diverse biological activities (2010, background): “It is therefore unsurprising that several publications have focused on the discovery of new active principles from fungi (Steglich 1981; Lorenzen and Anke 1998; Wasser 2002; Lindequist et al. 2005).”
- Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: Structure and potential prebiotic activity (2009, background): “The most of cultivated mushrooms such as Ganoderma lucidum, Lentinus edodes (Shiitake), Schizophyllum sp. and many others have been collected and used for centuries in Korea, China, Japan, and eastern Russia (Wasser, 2002).”
- Edible Mushrooms: Improving Human Health and Promoting Quality Life (2015, background): “of ediblemushrooms is nowadayswidely used and studied for its medicinal and therapeutic properties [40, 63, 64].”
- Antimicrobial Activities of Fruit Bodies and/or Mycelial Cultures of Some Mushroom Isolates (2006, background): “…activity (Espenshade & Griffith, 1966; Benedict & Brady, 1972; Anke, 1989; Bobek et al., 1991; Wang et al., 1995; Kiho et al., 1996; Kim et al., 1999; Suay et al., 2000; Hatvani, 2001; Byung-Keun et al., 2002; Wasser, 2002; Yang et al., 2002; Gao et al., 2005; Lindequist et al., 2005).”
- Structural elucidation of an exopolysaccharide from mycelial fermentation of a Tolypocladium sp. fungus isolated from wild Cordyceps sinensis (2010, background): “Because of their strong antitumor and immumodulation activities, a number of PS and PS-protein complexes derived from mushrooms or mycelial cultures have been commercialized as immunomodulation agents and adjuvant drugs for cancer therapy (Ooi & Liu, 2000; Wasser, 2002).”